dc.contributor.author | Killie, Ida Løken | |
dc.contributor.author | Braaten, Tonje | |
dc.contributor.author | Lorem, Geir F | |
dc.contributor.author | Borch, Kristin Benjaminsen | |
dc.date.accessioned | 2025-08-18T06:57:56Z | |
dc.date.available | 2025-08-18T06:57:56Z | |
dc.date.issued | 2025-08-13 | |
dc.description.abstract | Objectives - Self-rated health (SRH) is a well-established predictor of all-cause mortality. However, its predictive value in patients with cancer remains unclear. We aimed to elucidate the relationship between prediagnostic SRH and mortality among patients with cancer using data from the Norwegian Women and Health (NOWAC) Study.<p>
<p>Design - A prospective cohort study.<p>
<p>Settings and participants - This study included 26 405 women from the NOWAC cohort who were diagnosed with cancer between 1992 and 2020. Subgroup analyses focused on the most common cancer types among Norwegian women: breast (n=8299), colorectal (n=3653) and lung and bronchial (n=2428) cancers.<p>
<p>Primary and secondary outcome measures - Prediagnostic SRH was assessed using a single-item measure with four response alternatives and categorised into ‘very good’, ‘good’ and ‘poor’ SRH. We used flexible parametric survival analysis and competing risk regression models to evaluate the association between SRH and all-cause and cancer-specific mortality after adjusting for age, physical activity, Body Mass Index, smoking, alcohol consumption and education.<p>
<p>Results - Poor prediagnostic SRH was associated with increased all-cause mortality among long-term cancer survivors. For specific cancer sites, the adjusted HRs and 95% CI for poor versus very good SRH were 1.29 (95% CI: 1.06 to 1.58) for breast cancer and 1.50 (95% CI: 1.20 to 1.88) for colorectal cancer. These associations were more pronounced among long-term survivors than short-term survivors. No association was observed between prediagnostic SRH and mortality for patients with lung cancer. For cancer-specific mortality, prediagnostic SRH predicted mortality from all cancers, as well as from colorectal cancer.<p>
<p>Conclusions - Prediagnostic SRH is a significant predictor of mortality in patients with cancer, particularly among long-term survivors. These findings indicate the potential of SRH as a predictive tool for mortality, underscoring the importance of integrating SRH assessments into identifying individuals at higher risk of mortality and highlighting the potential benefits of public health interventions aimed at improving overall health, but further studies are required to assess the effect of such interventions on SRH. | en_US |
dc.identifier.citation | Killie, Braaten, Lorem, Borch. Prediagnostic self-rated health and survival in women diagnosed with cancer in the Norwegian Women and Health Study: a prospective cohort study. BMJ Open. 2025 | |
dc.identifier.cristinID | FRIDAID 2397497 | |
dc.identifier.doi | 10.1136/bmjopen-2025-099992 | |
dc.identifier.issn | 2044-6055 | |
dc.identifier.uri | https://hdl.handle.net/10037/37994 | |
dc.language.iso | eng | en_US |
dc.publisher | BMJ Publishing Group | en_US |
dc.relation.journal | BMJ Open | |
dc.relation.projectID | Norges forskningsråd: 289440 | |
dc.rights.holder | Copyright 2025 The Author(s) | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0 | en_US |
dc.rights | Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) | en_US |
dc.title | Prediagnostic self-rated health and survival in women diagnosed with cancer in the Norwegian Women and Health Study: a prospective cohort study | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |